Connect with us

Life Sciences

Chris Mason Takes Omics to Space

In this Qiagen sponsored GEN Keynote webinar, Christopher Mason, PhD, from Weill Cornell Medical College will describe the growing body of work in omics…

Published

on

This article was originally published by GEN Genetic Engineering and Biotechnology News

Broadcast Date: December 4, 2023
Time: 8:00 am PT, 11:00 am ET, 17:00 CET

Chris Mason’s lab at Cornell Medical School uses the latest tools and technologies in genomics to study clinical genetics including cancer, infectious disease, and how patients respond to different therapies. Their focus on omics exists both on Earth, and in space. Several years ago, Dr. Mason was a principal investigator for NASA’s landmark “Twins Study” which revealed key changes that occur to the genome when humans are in space, including the lengthening of telomeres in flight. The study involved the identical Kelly twins: Scott Kelly, an astronaut who spent a year in space and Senator Mark Kelly, who stayed on Earth. Today, with the increased pace of space travel (with about one launch every other day), comes an increase in Mason’s interest in omics and space.

In this GEN Keynote webinar, Mason will describe the growing body of work in this area. He’ll discuss recent advances, for example, the ability to perform DNA sequencing in flight, enabling the development of SOMA (Space Omics and Medical Atlas) tools and the new Aerospace Medicine Biobank, akin to the UK Biobank for space. He’ll also discuss the study of multi-omics profiling, chromatin remodeling, immune response, telomere stress, and the epitranscriptome. This work will increase our understanding of omics here on Earth and build the foundation of enabling genomics on the Moon and Mars.

A live Q&A session will follow the presentation, offering you a chance to pose questions to our expert panelist.

Chris Mason
Christopher Mason, PhD
Professor of Physiology and Biophysics
Weill Cornell Medical College

 

The post Chris Mason Takes Omics to Space appeared first on GEN – Genetic Engineering and Biotechnology News.


Life Sciences

Wittiest stocks:: Avalo Therapeutics Inc (NASDAQ:AVTX 0.00%), Nokia Corp ADR (NYSE:NOK 0.90%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Spellbinding stocks: LumiraDx Limited (NASDAQ:LMDX 4.62%), Transocean Ltd (NYSE:RIG -2.67%)

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well…

Continue Reading
Life Sciences

Asian Fund for Cancer Research announces Degron Therapeutics as the 2023 BRACE Award Venture Competition Winner

The Asian Fund for Cancer Research (AFCR) is pleased to announce that Degron Therapeutics was selected as the winner of the 2023 BRACE Award Venture Competition….

Continue Reading

Trending